Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease

Clinical trial NCT00048113 · COMPLETED

Trial details

NCT number: NCT00048113
Sponsor: Ionis Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2001-01-10
Primary completion: 2002-04-27
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.